Premium
Protagonist Therapeutics Inc (PTGX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| BlackRock, Inc. | Institution | 9 779 336 | 15,21% | US$ 1,19B | 2026-03-31 |
| Farallon Capital Management, L.L.C. | Institution | 6 348 906 | 9,87% | US$ 773,80M | 2026-03-31 |
| UBS Asset Management AG | Institution | 5 285 233 | 8,22% | US$ 644,16M | 2026-03-31 |
| RTW Investments, LP | Institution | 5 059 053 | 7,87% | US$ 616,60M | 2026-03-31 |
| Farallon Healthcare Partners Master, L.P. | Institution | 4 767 564 | 7,41% | US$ 581,07M | 2025-12-31 |
| Wellington Management Group LLP | Institution | 3 599 644 | 5,60% | US$ 438,72M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 3 481 211 | 5,41% | US$ 424,29M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 3 116 749 | 4,85% | US$ 379,87M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 2 891 527 | 4,50% | US$ 352,42M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 2 805 896 | 4,36% | US$ 341,98M | 2026-03-31 |
| Johnson & Johnson Innovation - JJDC, Inc. | Institution | 2 449 183 | 3,81% | US$ 298,51M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 1 715 691 | 2,67% | US$ 209,11M | 2025-09-30 |
| Geode Capital Management, LLC | Institution | 1 669 371 | 2,60% | US$ 203,46M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1 665 497 | 2,59% | US$ 202,99M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 551 900 | 2,41% | US$ 189,15M | 2026-03-31 |
| Invesco Ltd. | Institution | 1 517 153 | 2,36% | US$ 184,91M | 2026-03-31 |
| Woodline Partners LP | Institution | 1 414 173 | 2,20% | US$ 172,36M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 323 333 | 2,06% | US$ 161,29M | 2025-09-30 |
| Perceptive Advisors LLC | Institution | 1 230 879 | 1,91% | US$ 150,02M | 2026-03-31 |
| Bank of America Corporation | Institution | 1 184 301 | 1,84% | US$ 144,34M | 2026-03-31 |
| Jennison Associates LLC | Institution | 1 072 011 | 1,67% | US$ 130,66M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 1 045 774 | 1,63% | US$ 127,46M | 2025-09-30 |
| ADAR1 Capital Management, LLC | Institution | 994 119 | 1,55% | US$ 121,16M | 2026-03-31 |
| Hood River Capital Management LLC | Institution | 829 285 | 1,29% | US$ 101,07M | 2026-03-31 |
| Morgan Stanley | Institution | 801 304 | 1,25% | US$ 97,66M | 2026-03-31 |
| Driehaus Capital Management LLC | Institution | 720 928 | 1,12% | US$ 87,87M | 2026-03-31 |
| FMR LLC | Institution | 661 236 | 1,03% | US$ 80,59M | 2026-03-31 |
| Invesco Capital Management LLC | Institution | 647 517 | 1,01% | US$ 78,92M | 2026-03-31 |
| Marshall Wace LLP | Institution | 628 075 | 0,98% | US$ 76,55M | 2026-03-31 |
| ClearBridge Investments, LLC | Institution | 621 820 | 0,97% | US$ 75,79M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 593 197 | 0,92% | US$ 72,30M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 587 968 | 0,91% | US$ 71,66M | 2026-03-31 |
| Pictet Asset Management Limited | Institution | 581 083 | 0,90% | US$ 70,82M | 2026-03-31 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | Institution | 571 825 | 0,89% | US$ 69,69M | 2026-03-31 |
| Farallon Capital Offshore Investors II, L.P | Institution | 565 080 | 0,88% | US$ 68,87M | 2025-12-31 |
| Charles Schwab Investment Management, Inc. | Institution | 552 968 | 0,86% | US$ 67,40M | 2026-03-31 |
| American Century Investment Management Inc | Institution | 537 320 | 0,84% | US$ 65,49M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
